ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 56 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $28,000 | -56.9% | 29,174 | -46.3% | 0.00% | – |
| Q2 2015 | $65,000 | +160.0% | 54,347 | +132.5% | 0.00% | – |
| Q3 2014 | $25,000 | -95.7% | 23,379 | -95.8% | 0.00% | -100.0% |
| Q1 2014 | $579,000 | +291.2% | 562,822 | +342.3% | 0.00% | – |
| Q4 2013 | $148,000 | -65.2% | 127,249 | -49.6% | 0.00% | -100.0% |
| Q3 2013 | $425,000 | +123.7% | 252,501 | +165.2% | 0.00% | – |
| Q2 2013 | $190,000 | – | 95,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 4,337,858 | $5,032,000 | 0.14% |
| PRICE MICHAEL F | 748,200 | $868,000 | 0.11% |
| ALGERT GLOBAL LLC | 124,891 | $145,000 | 0.04% |
| Rotella Capital Management, Inc. | 13,701 | $16,000 | 0.03% |
| Icahn Capital | 5,904,863 | $6,850,000 | 0.02% |
| Spark Investment Management LLC | 110,100 | $127,000 | 0.02% |
| FCG ADVISORS, LLC | 20,000 | $23,000 | 0.02% |
| BRANDES INVESTMENT PARTNERS, LP | 1,023,893 | $1,188,000 | 0.02% |
| GLOBEFLEX CAPITAL L P | 101,454 | $117,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 129,089 | $149,000 | 0.01% |